Muhammad Wahab Amjad

1.8k citations
54 papers · 1.4k indexed · 1 hit paper · h-index 20
Topics
Advanced Drug Delivery Systems (15 papers)Synthesis and biological activity (12 papers)Nanoparticle-Based Drug Delivery (11 papers)

In The Last Decade

Muhammad Wahab Amjad

53 papers receiving 1.4k citations

Hit Papers

Nanoparticles incorporated hydrogels for delivery of anti...2024202620252024204060

Peers

Muhammad Wahab Amjad
Comparison fields: 5 of 124
  • Molecular Biology 439
  • Organic Chemistry 395
  • Biomaterials 285
  • Molecular Medicine 244
  • Pharmaceutical Science 175
Replace Hwa Jeong Lee with:
Hwa Jeong Lee South Korea
M. Yasmin Begum Saudi Arabia
Abolfazl Barzegar Iran
Abid Naeem China
Divya Dheer India
Hitesh Kulhari India
Hibah M. Aldawsari Saudi Arabia
Xiaoqing Cai China
Dhanalekshmi Unnikrishnan Meenakshi India
Karthikeyan Elumalai India
Muhammad Wahab Amjad relative to Hwa Jeong Lee South Korea Hwa Jeong Lee's profile →
Citations per field
00.5×
Hwa Jeong Lee · 1×
Citations per year

Countries citing papers authored by Muhammad Wahab Amjad

Since Specialization
Citations

This map shows the geographic impact of Muhammad Wahab Amjad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Wahab Amjad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Wahab Amjad more than expected).

Fields of papers citing papers by Muhammad Wahab Amjad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Wahab Amjad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Wahab Amjad. The network helps show where Muhammad Wahab Amjad may publish in the future.

Co-authorship network of co-authors of Muhammad Wahab Amjad

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Wahab Amjad. A scholar is included among the top collaborators of Muhammad Wahab Amjad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Wahab Amjad. Muhammad Wahab Amjad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2
Nanoparticles incorporated hydrogels for delivery of antimicrobial agents: developments and trendsbreakdown →
68
3 44
4 3
5 10
6 3
7 19
8 23
9
Development of thiomer based buccal films for the enhancement of bioavailability: An in-vivo analysis.
5
10
Development and optimization of flurbiprofen loaded microsponges; an in-vitro evaluation.
1
11 64
12 232
13 31
14 24
15 24
16 79
17 42
18 12
19 24
20 34

About Muhammad Wahab Amjad

Muhammad Wahab Amjad is a scholar working on Pharmaceutical Science, Molecular Medicine and Biomaterials, having authored 54 papers that have together received 1.4k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (15 papers), Synthesis and biological activity (12 papers) and Nanoparticle-Based Drug Delivery (11 papers). The work is most often cited by research in Molecular Medicine (244 citations), Pharmaceutical Science (175 citations) and Biomaterials (285 citations). Muhammad Wahab Amjad has collaborated with scholars based in Saudi Arabia, Pakistan and Malaysia. Frequent co-authors include Syed Nasir Abbas Bukhari, Mohd Cairul Iqbal Mohd Amin, Arun K. Iyer, Prashant Kesharwani, Maria Abdul Ghafoor Raja, Zahid Hussain, Ibrahim Jantan, Muhammad Ajaz Hussain, Shahzeb Khan and Tarek A. Ahmed. Their work appears in journals such as PLoS ONE, Progress in Polymer Science and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026